Westlake Chemical Corporation - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Westlake Chemical Corporation on August 18, 2006. The filing discloses a material definitive agreement regarding the revision of compensation packages for the Company's non-management directors, effective October 1, 2006.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on director compensation adjustments.
Material Changes
The Board of Directors approved changes to the cash compensation and equity awards for non-management directors. The specific adjustments include:
- Annual Cash Compensation: Set at $55,000 for all directors. Additional fees apply for committee chairs: $10,000 for the Audit Committee Chair and $5,000 each for the Compensation Committee and Nominating & Governance Committee Chairs.
- Stock Options: Each director received 1,345 stock options with an exercise price of $30.07. Options vest in 25% annual installments from 2007 to 2010 and expire in 2016.
- Restricted Stock: Each director received 831 shares of restricted stock, vesting in one-third installments annually from 2007 to 2009.
- Audit Committee Fees: Additional fees of $1,000 for physical meetings and $500 for telephonic meetings exceeding five per year.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The equity awards are subject to the grantees maintaining their continuous position as directors. The awards were granted pursuant to the Company's 2004 Omnibus Incentive Plan.
Key Facts for Investor Verification
- Verify the total number of non-management directors to calculate the aggregate cash and equity cost of this compensation plan.
- Confirm the impact of the $30.07 exercise price relative to the current market price of Westlake Chemical stock.
- Review the 2004 Omnibus Incentive Plan (Exhibit 10.1) for any caps on total equity grants or dilution limits.
- Monitor future filings to ensure the vesting schedules for options and restricted stock are adhered to.